Contact
searchSearch
HMP Global

Featured Topics

Type 2 Inflammation Learning Library

Featured Video

Vivian Shi
Rapid Refresh
Head and Neck Eczema
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP

Kimberly McPeeks
Clinical Pearls
Allergic Contact Dermatitis
09/15/2025
Kimberly Kincaid McPeeks, MPAS, PA-C
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key...
09/15/2025
The Derm APP
Vivian Shi
Rapid Refresh
Head and Neck Eczema
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP
Daniel Butler
Rapid Refresh
Role of Th2 Immune System in Dermatology
07/15/2025
Daniel C. Butler, MD
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the...
07/15/2025
The Derm APP
Lakshi Aldredge
Rapid Refresh
Type 2 Inflammation and Treatment Targets in Atopic Dermatitis
06/15/2025
Lakshi Aldredge, NP
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge...
06/15/2025
The Derm APP
Steven R. Feldman, MD, PhD
Clinical Pearls
Adherence to Atopic Dermatitis Treatment
05/15/2025
Steven R. Feldman, MD, PhD
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical...
05/15/2025
The Derm APP
Lauren McGrath
Clinical Pearls
Systemic Treatments for Type 2 Inflammation
04/15/2025
Lauren McGrath
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments...
04/15/2025
The Derm APP
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical...
03/15/2025
The Derm APP
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
The Derm APP
Steven Feldman
Rapid Refresh
Type 2 Inflammation in Atopic Dermatitis
01/13/2025
Steven R. Feldman, MD, PhD
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
The Derm APP
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
Gil Yosipovitch, MD
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
The Derm APP
Andrea Nguyen
Clinical Pearls
Vitiligo: Addressing Barriers to Care
09/25/2025
Andrea Nguyen, DMSc, MPAS, PA-C
Explore how NPs and PAs can overcome access barriers and support individualized care for patients with vitiligo.
Explore how NPs and PAs can overcome access barriers and support individualized care for patients with vitiligo.
Explore how NPs and PAs can...
09/25/2025
The Derm APP
Kimberly McPeeks
Clinical Pearls
Allergic Contact Dermatitis
09/15/2025
Kimberly Kincaid McPeeks, MPAS, PA-C
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key...
09/15/2025
The Derm APP
Peggy Vernon
Clinical Pearls
Topical Therapies for Pediatric AD
09/05/2025
Peggy Vernon, RN, MA, CPNP, DCNP, FAANP
A review of topical treatments for pediatric atopic dermatitis, from calcineurin inhibitors to newer options like crisaborole and ruxolitinib.
A review of topical treatments for pediatric atopic dermatitis, from calcineurin inhibitors to newer options like crisaborole and ruxolitinib.
A review of topical treatments...
09/05/2025
The Derm APP
Peter Lio
Clinical Pearls
How to Approach Integrative Medicine
08/25/2025
Peter Lio, MD, FAAD
Integrative medicine bridges conventional treatments with complementary approaches, offering a holistic, patient-centered strategy for dermatologic care.
Integrative medicine bridges conventional treatments with complementary approaches, offering a holistic, patient-centered strategy for dermatologic care.
Integrative medicine bridges...
08/25/2025
The Derm APP
Vivian Shi
Rapid Refresh
Head and Neck Eczema
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP
Jeffrey M. Cohen, MD
Clinical Pearls
Multiple Sclerosis and Psoriasis
08/05/2025
Jeff Cohen
Dr Cohen examines the complex relationship between psoriasis and multiple sclerosis (MS), focusing on the impact of TNF-alpha inhibitors.
Dr Cohen examines the complex relationship between psoriasis and multiple sclerosis (MS), focusing on the impact of TNF-alpha inhibitors.
Dr Cohen examines the complex...
08/05/2025
The Derm APP
David Rosmarin
Rapid Refresh
Types of Vitiligo
07/25/2025
David Rosmarin, MD
Learn to distinguish between segmental and non-segmental vitiligo, identify signs of active disease, and explore clinical features like confetti depigmentation, trichrome patterns, and Koebner phenomenon in this detailed breakdown.
Learn to distinguish between segmental and non-segmental vitiligo, identify signs of active disease, and explore clinical features like confetti depigmentation, trichrome patterns, and Koebner phenomenon in this detailed breakdown.
Learn to distinguish between...
07/25/2025
The Derm APP
Daniel Butler
Rapid Refresh
Role of Th2 Immune System in Dermatology
07/15/2025
Daniel C. Butler, MD
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the...
07/15/2025
The Derm APP
Nnenna Agim
Clinical Pearls
Assessing and Managing Infectious Disease in Children
07/05/2025
Nnenna Agim, MD
Dr Agim highlights the importance of precise diagnostic techniques, such as PCR swabs and cultures, in pediatric infectious disease management.
Dr Agim highlights the importance of precise diagnostic techniques, such as PCR swabs and cultures, in pediatric infectious disease management.
Dr Agim highlights the...
07/05/2025
The Derm APP
Ted Lain
Clinical Pearls
Clinical Classifications and Treatment Approaches for Actinic Keratosis
06/26/2025
Ted Lain, MD
In this video, Dr Lain explains the Olsen scale for grading actinic keratosis (AK), distinguishing between mild, moderate, and hyperkeratotic lesions, with a focus on their treatment and differentiation from squamous cell carcinoma in situ.
In this video, Dr Lain explains the Olsen scale for grading actinic keratosis (AK), distinguishing between mild, moderate, and hyperkeratotic lesions, with a focus on their treatment and differentiation from squamous cell carcinoma in situ.
In this video, Dr Lain explains...
06/26/2025
The Derm APP

Multimedia

Kimberly McPeeks
Clinical Pearls
Allergic Contact Dermatitis
09/15/2025
Kimberly Kincaid McPeeks, MPAS, PA-C
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key...
09/15/2025
The Derm APP
Vivian Shi
Rapid Refresh
Head and Neck Eczema
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP
Daniel Butler
Rapid Refresh
Role of Th2 Immune System in Dermatology
07/15/2025
Daniel C. Butler, MD
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the...
07/15/2025
The Derm APP
Lakshi Aldredge
Rapid Refresh
Type 2 Inflammation and Treatment Targets in Atopic Dermatitis
06/15/2025
Lakshi Aldredge, NP
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge...
06/15/2025
The Derm APP
Steven R. Feldman, MD, PhD
Clinical Pearls
Adherence to Atopic Dermatitis Treatment
05/15/2025
Steven R. Feldman, MD, PhD
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical...
05/15/2025
The Derm APP
Lauren McGrath
Clinical Pearls
Systemic Treatments for Type 2 Inflammation
04/15/2025
Lauren McGrath
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments...
04/15/2025
The Derm APP
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical...
03/15/2025
The Derm APP
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
The Derm APP
Steven Feldman
Rapid Refresh
Type 2 Inflammation in Atopic Dermatitis
01/13/2025
Steven R. Feldman, MD, PhD
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
The Derm APP
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
Gil Yosipovitch, MD
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
The Derm APP
Andrea Nguyen
Clinical Pearls
Vitiligo: Addressing Barriers to Care
09/25/2025
Andrea Nguyen, DMSc, MPAS, PA-C
Explore how NPs and PAs can overcome access barriers and support individualized care for patients with vitiligo.
Explore how NPs and PAs can overcome access barriers and support individualized care for patients with vitiligo.
Explore how NPs and PAs can...
09/25/2025
The Derm APP
Kimberly McPeeks
Clinical Pearls
Allergic Contact Dermatitis
09/15/2025
Kimberly Kincaid McPeeks, MPAS, PA-C
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
Kimberly McPeaks explores key...
09/15/2025
The Derm APP
Peggy Vernon
Clinical Pearls
Topical Therapies for Pediatric AD
09/05/2025
Peggy Vernon, RN, MA, CPNP, DCNP, FAANP
A review of topical treatments for pediatric atopic dermatitis, from calcineurin inhibitors to newer options like crisaborole and ruxolitinib.
A review of topical treatments for pediatric atopic dermatitis, from calcineurin inhibitors to newer options like crisaborole and ruxolitinib.
A review of topical treatments...
09/05/2025
The Derm APP
Peter Lio
Clinical Pearls
How to Approach Integrative Medicine
08/25/2025
Peter Lio, MD, FAAD
Integrative medicine bridges conventional treatments with complementary approaches, offering a holistic, patient-centered strategy for dermatologic care.
Integrative medicine bridges conventional treatments with complementary approaches, offering a holistic, patient-centered strategy for dermatologic care.
Integrative medicine bridges...
08/25/2025
The Derm APP
Vivian Shi
Rapid Refresh
Head and Neck Eczema
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP
Jeffrey M. Cohen, MD
Clinical Pearls
Multiple Sclerosis and Psoriasis
08/05/2025
Jeff Cohen
Dr Cohen examines the complex relationship between psoriasis and multiple sclerosis (MS), focusing on the impact of TNF-alpha inhibitors.
Dr Cohen examines the complex relationship between psoriasis and multiple sclerosis (MS), focusing on the impact of TNF-alpha inhibitors.
Dr Cohen examines the complex...
08/05/2025
The Derm APP
David Rosmarin
Rapid Refresh
Types of Vitiligo
07/25/2025
David Rosmarin, MD
Learn to distinguish between segmental and non-segmental vitiligo, identify signs of active disease, and explore clinical features like confetti depigmentation, trichrome patterns, and Koebner phenomenon in this detailed breakdown.
Learn to distinguish between segmental and non-segmental vitiligo, identify signs of active disease, and explore clinical features like confetti depigmentation, trichrome patterns, and Koebner phenomenon in this detailed breakdown.
Learn to distinguish between...
07/25/2025
The Derm APP
Daniel Butler
Rapid Refresh
Role of Th2 Immune System in Dermatology
07/15/2025
Daniel C. Butler, MD
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the...
07/15/2025
The Derm APP
Nnenna Agim
Clinical Pearls
Assessing and Managing Infectious Disease in Children
07/05/2025
Nnenna Agim, MD
Dr Agim highlights the importance of precise diagnostic techniques, such as PCR swabs and cultures, in pediatric infectious disease management.
Dr Agim highlights the importance of precise diagnostic techniques, such as PCR swabs and cultures, in pediatric infectious disease management.
Dr Agim highlights the...
07/05/2025
The Derm APP
Ted Lain
Clinical Pearls
Clinical Classifications and Treatment Approaches for Actinic Keratosis
06/26/2025
Ted Lain, MD
In this video, Dr Lain explains the Olsen scale for grading actinic keratosis (AK), distinguishing between mild, moderate, and hyperkeratotic lesions, with a focus on their treatment and differentiation from squamous cell carcinoma in situ.
In this video, Dr Lain explains the Olsen scale for grading actinic keratosis (AK), distinguishing between mild, moderate, and hyperkeratotic lesions, with a focus on their treatment and differentiation from squamous cell carcinoma in situ.
In this video, Dr Lain explains...
06/26/2025
The Derm APP

News

doctors
News
Dupilumab Shows Promise in Reducing COPD Exacerbations and Improving Lung Function
06/20/2025
Riya Gandhi, MA
Could a targeted biologic therapy change the treatment landscape for COPD patients with type 2 inflammation?
Could a targeted biologic therapy change the treatment landscape for COPD patients with type 2 inflammation?
Could a targeted biologic...
06/20/2025
The Derm APP
children
News
Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status
05/28/2025
Riya Gandhi, MA
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that...
05/28/2025
The Derm APP
AD
News
Dupilumab Effective in Young Children with Eczema, Regardless of Type 2 Inflammatory Comorbidities
04/10/2025
Riya Gandhi, MA
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab...
04/10/2025
The Derm APP
telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
The Derm APP
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
The Derm APP
SOC
News
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
The Derm APP
Atopic dermatitis
News
Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
The Derm APP
Atopic dermatitis
News
New Screening Tool Promotes Multidisciplinary Approach to Type 2 Inflammation-Related Diseases
01/07/2025
Riya Gandhi, MA
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
The Derm APP
doctors
News
Dupilumab Shows Promise in Reducing COPD Exacerbations and Improving Lung Function
06/20/2025
Riya Gandhi, MA
Could a targeted biologic therapy change the treatment landscape for COPD patients with type 2 inflammation?
Could a targeted biologic therapy change the treatment landscape for COPD patients with type 2 inflammation?
Could a targeted biologic...
06/20/2025
The Derm APP
children
News
Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status
05/28/2025
Riya Gandhi, MA
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that...
05/28/2025
The Derm APP
AD
News
Dupilumab Effective in Young Children with Eczema, Regardless of Type 2 Inflammatory Comorbidities
04/10/2025
Riya Gandhi, MA
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab...
04/10/2025
The Derm APP
telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
The Derm APP
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
The Derm APP
SOC
News
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
The Derm APP
Atopic dermatitis
News
Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
The Derm APP
Atopic dermatitis
News
New Screening Tool Promotes Multidisciplinary Approach to Type 2 Inflammation-Related Diseases
01/07/2025
Riya Gandhi, MA
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
The Derm APP

Quizzes

Quiz
What’s the Gold Standard in Managing Chronic TH2 Dermatoses?
08/27/2025
Riya Gandhi, MA
Flares are only part of the story. Quiz yourself on the chronic TH2 skin conditions.
Flares are only part of the story. Quiz yourself on the chronic TH2 skin conditions.
Flares are only part of the...
08/27/2025
The Derm APP
Quiz
Th2 vs Th1: Can You Differentiate PN from Psoriasis?
08/20/2025
Riya Gandhi, MA
When is pruritus more than just a symptom? Take the quiz and identify key clinical signs pointing to Th2-driven diseases like prurigo nodularis.
When is pruritus more than just a symptom? Take the quiz and identify key clinical signs pointing to Th2-driven diseases like prurigo nodularis.
When is pruritus more than just...
08/20/2025
The Derm APP
Quiz
What Sets JAK Inhibitors Apart in Th2 Dermatoses?
08/13/2025
Riya Gandhi, MA
Test your clinical insight on how JAK inhibitors differ from traditional systemic agents like methotrexate.
Test your clinical insight on how JAK inhibitors differ from traditional systemic agents like methotrexate.
Test your clinical insight on...
08/13/2025
The Derm APP
Quiz
Why Do Biologics Like Dupilumab Work in AD?
08/06/2025
Riya Gandhi, MA
Do you know the rationale behind using biologics like dupilumab in TH2-driven diseases? Quiz yourself on the science behind targeted biologic therapies
Do you know the rationale behind using biologics like dupilumab in TH2-driven diseases? Quiz yourself on the science behind targeted biologic therapies
Do you know the rationale behind...
08/06/2025
The Derm APP
Quiz
Key Immune Markers of TH2 Skin Disease: Can You Spot Them?
08/01/2025
Riya Gandhi, MA
Take the quiz to test your understanding of which immunologic changes define TH2-driven conditions like AD.
Take the quiz to test your understanding of which immunologic changes define TH2-driven conditions like AD.
Take the quiz to test your...
08/01/2025
The Derm APP
Quiz
Comorbid Clues: What Conditions Suggest Type 2 Inflammation?
07/22/2025
Riya Gandhi, MA
Some diagnoses can point toward broader type 2 immune involvement. Quiz yourself on which comorbidities may influence treatment decisions in AD.
Some diagnoses can point toward broader type 2 immune involvement. Quiz yourself on which comorbidities may influence treatment decisions in AD.
Some diagnoses can point toward...
07/22/2025
The Derm APP
Quiz
IL-4 and IL-13 in AD: What's Their Pathogenic Power?
07/14/2025
Riya Gandhi, MA
IL-4 and IL-13 are central to AD—but why? Take the quiz and assess your understanding of their roles in IgE sensitization and immune dysregulation.
IL-4 and IL-13 are central to AD—but why? Take the quiz and assess your understanding of their roles in IgE sensitization and immune dysregulation.
IL-4 and IL-13 are central to...
07/14/2025
The Derm APP
Quiz
Which Immune Cell Doesn’t Drive Type 2 Inflammation?
07/07/2025
Riya Gandhi, MA
Test your immunology IQ: Can you identify the immune cell not typically involved in driving cytokine activity in type 2 inflammatory skin conditions like AD and PN?
Test your immunology IQ: Can you identify the immune cell not typically involved in driving cytokine activity in type 2 inflammatory skin conditions like AD and PN?
Test your immunology IQ: Can you...
07/07/2025
The Derm APP
Molecule
Quiz
Test Your Knowledge: Key Cytokines in Atopic Dermatitis
05/14/2025
Riya Gandhi, MA
Can you identify the cytokines driving type 2 inflammation in atopic dermatitis? Take this quick quiz to reinforce your clinical understanding.
Can you identify the cytokines driving type 2 inflammation in atopic dermatitis? Take this quick quiz to reinforce your clinical understanding.
Can you identify the cytokines...
05/14/2025
The Derm APP
Atopic dermatitis
Quiz
Topical Treatment Challenges in Type 2 Inflammatory Skin Conditions
04/20/2025
Riya Gandhi, MA
Discover why determining the best topical therapy for type 2 inflammation is complex. This quiz explores key issues like patient compliance and the lack of head-to-head clinical trials in dermatology.
Discover why determining the best topical therapy for type 2 inflammation is complex. This quiz explores key issues like patient compliance and the lack of head-to-head clinical trials in dermatology.
Discover why determining the...
04/20/2025
The Derm APP
Quiz
What’s the Gold Standard in Managing Chronic TH2 Dermatoses?
08/27/2025
Riya Gandhi, MA
Flares are only part of the story. Quiz yourself on the chronic TH2 skin conditions.
Flares are only part of the story. Quiz yourself on the chronic TH2 skin conditions.
Flares are only part of the...
08/27/2025
The Derm APP
Quiz
Th2 vs Th1: Can You Differentiate PN from Psoriasis?
08/20/2025
Riya Gandhi, MA
When is pruritus more than just a symptom? Take the quiz and identify key clinical signs pointing to Th2-driven diseases like prurigo nodularis.
When is pruritus more than just a symptom? Take the quiz and identify key clinical signs pointing to Th2-driven diseases like prurigo nodularis.
When is pruritus more than just...
08/20/2025
The Derm APP
Quiz
What Sets JAK Inhibitors Apart in Th2 Dermatoses?
08/13/2025
Riya Gandhi, MA
Test your clinical insight on how JAK inhibitors differ from traditional systemic agents like methotrexate.
Test your clinical insight on how JAK inhibitors differ from traditional systemic agents like methotrexate.
Test your clinical insight on...
08/13/2025
The Derm APP
Quiz
Why Do Biologics Like Dupilumab Work in AD?
08/06/2025
Riya Gandhi, MA
Do you know the rationale behind using biologics like dupilumab in TH2-driven diseases? Quiz yourself on the science behind targeted biologic therapies
Do you know the rationale behind using biologics like dupilumab in TH2-driven diseases? Quiz yourself on the science behind targeted biologic therapies
Do you know the rationale behind...
08/06/2025
The Derm APP
Quiz
Key Immune Markers of TH2 Skin Disease: Can You Spot Them?
08/01/2025
Riya Gandhi, MA
Take the quiz to test your understanding of which immunologic changes define TH2-driven conditions like AD.
Take the quiz to test your understanding of which immunologic changes define TH2-driven conditions like AD.
Take the quiz to test your...
08/01/2025
The Derm APP
Quiz
Comorbid Clues: What Conditions Suggest Type 2 Inflammation?
07/22/2025
Riya Gandhi, MA
Some diagnoses can point toward broader type 2 immune involvement. Quiz yourself on which comorbidities may influence treatment decisions in AD.
Some diagnoses can point toward broader type 2 immune involvement. Quiz yourself on which comorbidities may influence treatment decisions in AD.
Some diagnoses can point toward...
07/22/2025
The Derm APP
Quiz
IL-4 and IL-13 in AD: What's Their Pathogenic Power?
07/14/2025
Riya Gandhi, MA
IL-4 and IL-13 are central to AD—but why? Take the quiz and assess your understanding of their roles in IgE sensitization and immune dysregulation.
IL-4 and IL-13 are central to AD—but why? Take the quiz and assess your understanding of their roles in IgE sensitization and immune dysregulation.
IL-4 and IL-13 are central to...
07/14/2025
The Derm APP
Quiz
Which Immune Cell Doesn’t Drive Type 2 Inflammation?
07/07/2025
Riya Gandhi, MA
Test your immunology IQ: Can you identify the immune cell not typically involved in driving cytokine activity in type 2 inflammatory skin conditions like AD and PN?
Test your immunology IQ: Can you identify the immune cell not typically involved in driving cytokine activity in type 2 inflammatory skin conditions like AD and PN?
Test your immunology IQ: Can you...
07/07/2025
The Derm APP
Quiz
Does a 1-Week Follow-Up Improve Pediatric AD Outcomes?
06/27/2025
Riya Gandhi, MA
Early intervention matters—but how much? Test your knowledge on the effects of early follow-up after initiating topical tacrolimus in children with atopic dermatitis.
Early intervention matters—but how much? Test your knowledge on the effects of early follow-up after initiating topical tacrolimus in children with atopic dermatitis.
Early intervention matters—but...
06/27/2025
The Derm APP
Quiz
What Did Objective Monitoring Reveal About Pediatric Steroid Use?
06/27/2025
Riya Gandhi, MA
Electronic monitoring tells a different story—do you know how children with AD are actually using their medications? Take the quiz to explore this real-world evidence.
Electronic monitoring tells a different story—do you know how children with AD are actually using their medications? Take the quiz to explore this real-world evidence.
Electronic monitoring tells a...
06/27/2025
The Derm APP
The Derm APP

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.

The Derm APP is designed for Advanced Practice Providers who specialize in Dermatology, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with dermatology. Engage year-round with The Dermatologist to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use